CENPF and non-Hodgkin lymphoma: In 2005, a radio-immunological assay was used to compare 347 non-Hodgkin’s lymphoma patients and 150 control subjects, and the proportions of CENPF detected in the two groups were 7.2% and 1.3% (p < 0.05), respectively, suggesting that CENPF may play a role in the development and progression of some types of NHL (Bencimon et al., 2005).